Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Ketrosden Triasmitra Tbk. (KETR) vs UBC Medical Indonesia Tbk. (LABS)

Ketrosden Triasmitra Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Ketrosden Triasmitra Tbk. dan UBC Medical Indonesia Tbk.: Ketrosden Triasmitra Tbk. diperdagangkan di Rp955 (kapitalisasi pasar 2,64 T, volume 24 jam 92,24 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb). Perbedaan utamanya: Ketrosden Triasmitra Tbk. jauh lebih besar — sekitar 3,8× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Ketrosden Triasmitra Tbk. lebih aktif diperdagangkan (92,24 jt vs 635,5 rb). Mana yang lebih baik tergantung tujuan investasimu.

KETRLABS
Kapitalisasi Pasar
2,64 T691,25 M
Volume
92,24 jt635,5 rb
Lot
922,38 rb6,36 rb
Perputaran
90,37 M110,15 jt
Harga Rata-rata
979,8173,33
Nilai Transaksi
90,37 M110,15 jt
Harga Ekuilibrium Indikatif
955174
Volume Ekuilibrium Indikatif
29,3 rb50

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

KETR
Lihat detail
LABS
Lihat detail

Tentang Ketrosden Triasmitra Tbk.

PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.

Selengkapnya di halaman KETR

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS